-
BRCA: Who Should Be Tested?
Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.
by Sue Rochman
-
Forward Look
Screening for Lung Cancer in Rural AreasPrograms aim to increase awareness of benefits.
by Sue Rochman
-
Survivor Profile
Handle With CareBrain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.
by Lindsey Konkel
-
From the Editor-in-Chief
Human Papillomavirus Vaccines: Bad News, Good News and Great NewsIncreased vaccination rates can help reduce cervical cancer as a worldwide health threat.
by William G. Nelson, MD, PhD
-
Forward Look
Targeted Treatments for TotsNew law mandates that cancer drugs get tested in kids in clinical trials.
by Sharon Tregaskis
-
Turning Up the Heat on Cancer
Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments.
by Kendall K. Morgan
-
Forward Look
Early Chemotherapy Dose Reductions May Affect Breast Cancer OutcomesNew study explores impact of lowering dose due to side effects.
by Jane Langille
-
Forward Look
Medicare to Cover CAR-T Cell TherapyHigh cost may still limit access.
by Nancy Averett
-
Cancer Patient Advocates Find Strength in Numbers
Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.
by Marci A. Landsmann
-
Exploring Immunotherapy for Triple Negative Breast Cancer
Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.
by Marci A. Landsmann
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore